线粒体和间充质干细胞衍生的外泌体联合治疗大鼠急性呼吸窘迫综合征和脓毒症的结果。
Outcomes of combined mitochondria and mesenchymal stem cells-derived exosome therapy in rat acute respiratory distress syndrome and sepsis.
发表日期:2024 Jun 26
作者:
Kun-Chen Lin, Wen-Feng Fang, Jui-Ning Yeh, John Y Chiang, Hsin-Ju Chiang, Pei-Lin Shao, Pei-Hsun Sung, Hon-Kan Yip
来源:
ANTIOXIDANTS & REDOX SIGNALING
摘要:
急性呼吸窘迫综合征(ARDS)并发脓毒症综合征(SS)的治疗仍然具有挑战性。 探讨脂肪源性间充质干细胞(ADMSCs)衍生的外泌体(EXAD)和外源性线粒体(mitoEx)相结合是否可以保护肺部来自 ARDS 并发 SS。体外研究,包括用脂多糖 (LPS) 处理的 L2 细胞,以及体内研究,包括分为组 1(假手术对照)、2(ARDS-SS)、3 组的雄性成年 SD 大鼠(ARDS-SS EXAD)、4 (ARDS-SS mitoEx) 和 5 (ARDS-SS EXAD mitoEx) 均包含在本研究中。体外研究表明,在受体 L2 细胞中发现了丰富的 mitoEx,从而显着较高的线粒体细胞色素 C、三磷酸腺苷和相对线粒体 DNA 水平 (P < 0.001)。炎症蛋白水平[白细胞介素(IL)-1β/肿瘤坏死因子(TNF)-α/核因子-κB/Toll样受体(TLR)-4/基质金属蛋白酶(MMP)-9/氧化应激(在经过 EXAD 处理的脂多糖 (LPS) 处理的 L2 细胞中,与未经 EXAD 处理相比,NOX-1/NOX-2)/细胞凋亡 (cleaved-caspase3/cleaved-poly (ADP-ribose)polymerase)] 显着减弱,而蛋白质表达细胞连接[闭塞/β-连环蛋白/闭塞小带 (ZO)-1/E-钙粘蛋白]表现出相反的炎症模式(所有 P < 0.001)。 48小时-ARDS诱导后72小时处死动物,并收获肺组织。 72小时时,支气管肺泡灌洗液的流式细胞术分析表明,炎症细胞(Ly6G / CD14 / CD68 / CD11b / c /髓过氧化物酶)和白蛋白的水平在第1组中最低,在第2组中最高,在第3组中显着更高和 4 比第 5 组高(所有 P < 0.0001),而动脉血氧饱和度 (SaO2%) 在各组中显示出相反的白蛋白模式。肺损伤/纤维化区域和炎症/DNA 损伤标记物 (CD68 /γ-H2AX) 的组织病理学结果显示各组间 SaO2% 的模式相同(所有 P < 0.0001)。炎症蛋白(TLR-4/MMP-9/IL-1β/TNF-α)/氧化应激(NOX-1/NOX-2/p22phox/氧化蛋白)/线粒体损伤(胞质-细胞色素-C/动力相关蛋白 1)/自噬(beclin-1/Atg-5/LC3B-II/LC3B-I 比率)生物标志物表现出类似的方式,而抗氧化剂 [核呼吸因子 (Nrf)-1/Nrf-2]/细胞连接(ZO-1/E-钙粘蛋白)/线粒体电子传递链(复合物 I-V)在各组中表现出相反的白蛋白方式(所有 P < 0.0001)。 EXAD-mitoEx 组合疗法比单独一种疗法更能保护肺部对抗ARDS-SS引起的伤害。©作者2024。百事登出版集团有限公司出版。保留所有权利。
The treatment of acute respiratory distress syndrome (ARDS) complicated by sepsis syndrome (SS) remains challenging.To investigate whether combined adipose-derived mesenchymal-stem-cells (ADMSCs)-derived exosome (EXAD) and exogenous mitochondria (mitoEx) protect the lung from ARDS complicated by SS.In vitro study, including L2 cells treated with lipopolysaccharide (LPS) and in vivo study including male-adult-SD rats categorized into groups 1 (sham-operated-control), 2 (ARDS-SS), 3 (ARDS-SS + EXAD), 4 (ARDS-SS + mitoEx), and 5 (ARDS-SS + EXAD + mitoEx), were included in the present study.In vitro study showed an abundance of mitoEx found in recipient-L2 cells, resulting in significantly higher mitochondrial-cytochrome-C, adenosine triphosphate and relative mitochondrial DNA levels (P < 0.001). The protein levels of inflammation [interleukin (IL)-1β/tumor necrosis factor (TNF)-α/nuclear factor-κB/toll-like receptor (TLR)-4/matrix-metalloproteinase (MMP)-9/oxidative-stress (NOX-1/NOX-2)/apoptosis (cleaved-caspase3/cleaved-poly (ADP-ribose) polymerase)] were significantly attenuated in lipopolysaccharide (LPS)-treated L2 cells with EXAD treatment than without EXAD treatment, whereas the protein expressions of cellular junctions [occluding/β-catenin/zonula occludens (ZO)-1/E-cadherin] exhibited an opposite pattern of inflammation (all P < 0.001). Animals were euthanized by 72 h post-48 h-ARDS induction, and lung tissues were harvested. By 72 h, flow cytometric analysis of bronchoalveolar lavage fluid demonstrated that the levels of inflammatory cells (Ly6G+/CD14+/CD68+/CD11b/c+/myeloperoxidase+) and albumin were lowest in group 1, highest in group 2, and significantly higher in groups 3 and 4 than in group 5 (all P < 0.0001), whereas arterial oxygen-saturation (SaO2%) displayed an opposite pattern of albumin among the groups. Histopathological findings of lung injury/fibrosis area and inflammatory/DNA-damaged markers (CD68+/γ-H2AX) displayed an identical pattern of SaO2% among the groups (all P < 0.0001). The protein expressions of inflammatory (TLR-4/MMP-9/IL-1β/TNF-α)/oxidative stress (NOX-1/NOX-2/p22phox/oxidized protein)/mitochondrial-damaged (cytosolic-cytochrome-C/dynamin-related protein 1)/autophagic (beclin-1/Atg-5/ratio of LC3B-II/LC3B-I) biomarkers exhibited a similar manner, whereas antioxidants [nuclear respiratory factor (Nrf)-1/Nrf-2]/cellular junctions (ZO-1/E-cadherin)/mitochondrial electron transport chain (complex I-V) exhibited an opposite manner of albumin among the groups (all P < 0.0001).Combined EXAD-mitoEx therapy was better than merely one for protecting the lung against ARDS-SS induced injury.©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.